Corticosteroid Injection Effectiveness in Carpel Tunnel Patients With Negative or Mild EMG Studies

Part of paid clinical trials in Detroit, Michigan.

Sponsor
Henry Ford Health System
Study ID
NCT04737239
Status
Recruiting
Apply to this trial

Conditions

  • Carpal Tunnel Syndrome

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Corticosteroid injections for CTS treatment — OTHER
    Treatment of carpel tunnel syndrome with corticosteroid injections for EMG mild and EMG negative patients

Study Details

Carpal Tunnel Syndrome (CTS) is the most common nerve entrapment syndrome worldwide. There are currently no studies examining the effectiveness of corticosteroid injections in patients with normal (negative) EMG studies. The purpose of this study is to gain a better understanding of the duration of symptom improvement post corticosteroid injection in patients with negative or mild EMG studies. The Boston Carpal Tunnel Questionnaire will be given to patients undergoing corticosteroid injections for the treatment of carpal tunnel syndrome to assess their response to the injection. Investigators will collect data retrospectively. The Boston Carpal Tunnel Questionnaire (BCTQ) is administered as per standard protocol to all patients with CTS who have a negative or mild EMG study. The BCTQ assesses the patient's self-reported symptom severity and functional status. Investigators will analyze this data with respect to demographics as well as numbness in the median n. distribution, nocturnal numbness, weakness/atrophy of the thenar musculature, Tinel's sign, Phalen's test, loss of 2-point discrimination, Quick-Dash score, and grip strength score. The primary outcome will be the Boston Carpal Tunnel Questionnaire outcome score under the different EMG conditions.The secondary outcomes will be numbness in the median n. distribution, nocturnal numbness, weakness/atrophy of the thenar musculature, Tinel's sign, Phalen's test, loss of 2-point discrimination, QuickDash score, and grip strength score. Both outcomes will be examined in patients with negative or mild EMG readings. This information will allow orthopedic physicians to gain a better understanding of the duration of symptom improvement post-corticosteroid injection, allowing them to fine tune their treatment plans for CTS patients.

Key Dates

Start date
Dec 23, 2020
Status verified
Feb 2026
Primary completion
Mar 22, 2026
Completion
Dec 22, 2026

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: Patient with CTS/Mild EMG
  • Arm: Patient with CTS/Negative EMG

Primary Outcome Measure

Boston Carpel Tunnel Questionnaire [ Time Frame: Dec 23 2020-Dec 22 2021 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Henry Ford Health SystemDetroitMichigan48202
Charles S Day, M.D., M.B.A.
[email protected]
313-916-5846
Elizabeth A Washnock-Schmid, B.S.
[email protected]
8103474714
Charles S Day, MD, MBA (PRINCIPAL_INVESTIGATOR)

Find similar trials in Detroit, MI

By research site
Henry Ford Health System· Detroit, MI

Related Studies